In a previous retrospective study, patients with DS exhibited higher frequencies of truncating mutations and greater alterations in amino acid polarity compared to patients with GEFS+, supporting the involvement of SCN1A mutations in the clinical severity of DS [113]. This evidence concerns the gene SCN1A and Dravet syndrome.